Navigation Links
Hooper Holmes Announces Third Quarter 2007 Results
Date:11/9/2007

BASKING RIDGE, N.J., Nov. 9 /PRNewswire-FirstCall/ -- Hooper Holmes, Inc. (Amex: HH), a leading provider of healthcare assessment services, today announced financial results for the third quarter ended September 30, 2007.

Third quarter 2007 revenues were $56.3 million compared to $60.6 million in the corresponding period of 2006. The Company recorded a net loss for the third quarter of 2007 of $10.6 million, or $(0.16) per share, compared to a net loss of $42.1 million or $(0.63) per share in the prior year period. The net loss for the third quarter of 2007 includes a non-cash impairment charge for goodwill and intangibles of $6.3 million and $1.6 million of restructuring and other charges. The net loss for the third quarter of 2006 included a non- cash charge of $31.9 million related to an increase in the valuation allowance for deferred tax assets and $6.6 million of restructuring and other charges.

For the first nine months of 2007, total revenues were $179.4 million compared to $193.9 million in the comparable period of 2006. The Company's net loss for the first nine months of 2007 totaled $14.2 million, or $(0.21) per share, compared to a net loss of $44.1 million, or $(0.66) per share in the comparable period of 2006. The 2007 net loss includes a non-cash impairment charge for goodwill and intangibles of $6.3 million and $2.9 million of restructuring and other charges. The net loss for the first nine months of 2006 included a non-cash charge of $31.9 million related to an increase in the valuation allowance for deferred tax assets and $8.3 million related to restructuring and other charges.

Third quarter 2007 Results by Division

Health Information Division (HID)

The Company's Health I
'/>"/>

SOURCE Hooper Holmes, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Hooper Holmes Names Chris Behling President of Health & Wellness Division
2. Hooper Holmes Launches Health & Wellness Division at 2007 Disease Management Leadership Forum and Integrated Care Summit
3. Hooper Holmes Concludes Sale of Medicals Direct
4. Hooper Holmes to Exhibit at the 2007 Sixth Annual Association of Home Office Underwriters Conference
5. Hooper Holmes Introduces Mature Assessment
6. Hooper Holmes Announces Third Quarter Earnings Release Date and Conference Call Information
7. Hooper Holmes Appoints Leslie Hudson, PhD, to Board of Directors
8. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
9. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
10. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
11. HEI, Inc. Announces Sale of RFID Division Assets
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Las Colinas FREE Community Health Fair Benefiting the Shoh-Sohail Family of Irving 2Health News:Top Latin American Television Companies Commit to Addressing AIDS 2Health News:Top Latin American Television Companies Commit to Addressing AIDS 3Health News:Top Latin American Television Companies Commit to Addressing AIDS 4Health News:Beacon Equity Issues Technical Trade Alerts on Drug Manufacturers: JNJ, ABT, LLY, PFE, NVS, GSK 2Health News:Companion Global Healthcare Expands Service to Include Hospitals in Mexico 2Health News:LUMA Cervical Imaging System Installed in Edina at Minnesota Gynecology 2Health News:LUMA Cervical Imaging System Installed in Edina at Minnesota Gynecology 3Health News:Edge Health Solutions Selects Allscripts Electronic Health Record for Apple Mac OS X Medical Platform 2Health News:Edge Health Solutions Selects Allscripts Electronic Health Record for Apple Mac OS X Medical Platform 3Health News:Edge Health Solutions Selects Allscripts Electronic Health Record for Apple Mac OS X Medical Platform 4Health News:Edge Health Solutions Selects Allscripts Electronic Health Record for Apple Mac OS X Medical Platform 5
Breaking Medicine Technology:Al Novak Elected Chairman of the Board of OrbusNeich Medical 2National Ergonomics Expo Sees Immediate 93% Exhibit Space Renewal for 2010; Equipois, Herman Miller, Neutral Posture, REDpoint International Win 2009 Attendees' Choice New Product Awards 2PRA International Hosts an Infectious Diseases Audio Conference 2PRA International Hosts an Infectious Diseases Audio Conference 3Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 1Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 2Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 3Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 4Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 5Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 6Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 7Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 8Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 9Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 10Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 11Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 12Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 13Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 14Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 15Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 16Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 17Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 18Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 19Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 20Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 21Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 22Los Angeles Kerlan Jobe Orthopaedic Clinic Pays 243 Million to Settle Kickback Allegations 62394 1Los Angeles Kerlan Jobe Orthopaedic Clinic Pays 243 Million to Settle Kickback Allegations 62394 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately 2457 Million 15034 1PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately 2457 Million 15034 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately 2457 Million 15034 3